UAB Department of Neurology

Congratulations to Vamsi Singu, a UAB undergraduate researcher in the lab of Erik Roberson, M.D., Ph.D., on being named a 2026 Goldwater Scholar, one of the nation’s most prestigious awards for undergraduate research.

Singu, who studies neuroscience and conducts research at UAB, plans to pursue an M.D. and Ph.D. with the goal of identifying new therapeutic targets for neurodegenerative disease. This recognition highlights both academic excellence and a strong commitment to advancing scientific discovery.

Read more: https://buff.ly/TbOhZ1Z
UAB Heersink School of Medicine

Emma Hobby, Ph.D. student in the UAB Graduate Biomedical Sciences neurosciences theme, is earning international recognition for her research in Alzheimer’s disease.

Hobby won the Lightning Presentation Round at the 2025 International Tau Global Conference, where her talk, “Multimodal Networks Identify Synaptic Targets Related to Tau Seeds in Alzheimer’s Disease,” was selected as the top presentation among more than 10 speakers.

Her research uses advanced computational network approaches to analyze human data and identify promising therapeutic targets.

As a result of this achievement, she will present her work at the Alzheimer’s Association International Conference in London.

Read more: https://buff.ly/5zX5oNi

We’re proud to highlight one of our own, Rohit Dhall, M.D., a UAB Heersink School of Medicine Department of Neurology residency and fellowship alumnus now serving as chair of neurology at UAMS - University of Arkansas for Medical Sciences!

His leadership, dedication, and impact across the field make this recognition especially meaningful.

Read more: https://buff.ly/m56ZWZs

David G. Standaert, M.D., Ph.D., was featured in Science News Magazine discussing emerging tools that may help diagnose Parkinson’s disease earlier than ever.

The article highlights the challenges of diagnosing Parkinson’s, including its wide range of symptoms, and shares how researchers are exploring new approaches such as wearable technology, movement tracking, and biomarker testing to support earlier detection.

Read the full story: https://buff.ly/ekY3lOY
UAB Heersink School of Medicine

Please join us for the next Neurology Research Lunch and Learn on June 24! The topic is "Research Imaging & Image Guided Lumbar Punctures" Kindly register and share any questions/topics in advance by June 17: https://buff.ly/HXW3sH2

The UAB Heersink School of Medicine Department of Neurology recognized its graduating residents and fellows at a graduation ceremony on Thursday, June 4. We extend our deepest congratulations to our graduates and look forward to seeing where your careers take you next! ✨️

The 13th Annual Blazer Bolt for Brain Cancer brought together more than 1,000 participants and 60+ teams in a record-breaking show of support for brain cancer patients and research. From the 5K to the powerful Memorial & Survivor Walk, every step taken at Railroad Park honored patients, families, and the work being done right here at UAB.

We’re proud to be part of advancing care, research, and hope for those impacted by brain cancer.

More information: https://buff.ly/ecSjRs7

Victor Sung, M.D., was recently featured in NeurologyLive, where he shared new insights into Huntington disease research.

Three-year data on AMT-130 show promising signs of slowing disease progression, a meaningful step forward in a space where treatment options remain limited.

Hear more from Dr. Sung:

Understanding the 3-Year Findings Behind AMT-130 in Huntington Disease: Victor Sung, MD | NeurologyLive - Clinical Neurology News and Neurology Expert Insights The professor of neurology and director of the Division of Movement Disorders at the University of Alabama at Birmingham discussed 3-year data on AMT-130 and its potential as a disease-modifying gene therapy for Huntington disease. [WATCH TIME: 3 minutes]

Peter King, M.D., and Louis Nabors, M.D., were featured by the Bill L. Harbert Institute for Innovation and Entrepreneurship for their work on neuroinflammation.

Their research focuses on how inflammation contributes to damage in conditions like stroke and brain cancer, and what it could mean to target it more effectively with a therapy like SRI-42127.

Read more about their work:

UAB advances brain health research through targeting neuroinflammation | Bill L. Harbert Institute for Innovation and Entrepreneurship The Harbert Institute helps to translate University of Alabama at Birmingham (UAB) discoveries and ideas into new products and start-up businesses.

For decades, patients and families asked the same question: Can anything slow Alzheimer’s? Now, that answer is beginning to change.

UAB Heersink School of Medicine Department of Neurology is helping lead a new era of care with anti-amyloid therapies shown to slow disease progression. At the same time, the team has redesigned how Alzheimer’s care is delivered, building one of the nation’s largest programs with more than 300 patients in treatment.

By bringing neurologists, nurse practitioners, case managers, and social workers together in a coordinated care model, UAB is working to expand access and better support patients across Alabama.

Read how UAB is rethinking Alzheimer’s care: https://buff.ly/kXd8utZ

UAB Medicine | UAB - The University of Alabama at Birmingham